Both in Pharmaceuticals
Phibro Animal Health vs Innoviva
Over the past year PAHC returned −10.4% and INVA returned +17.2%; their daily moves had a correlation of 0.21.
PAHC −10.4% INVA +17.2%Growth of $1, one year, split-adjusted
| Metric | PAHC | INVA |
|---|---|---|
| Price | $38.88 | $21.22 |
| Market cap | $1.58B | $1.53B |
| Today | +0.05% | −0.42% |
| 1 month | +8.4% | +3.3% |
| 6 months | −29.2% | −8.2% |
| Year to date | +4.1% | +6.2% |
| 1 year | −5.6% | +20.8% |
| Revenue growth (YoY) | +4.8% | +19.3% |
| Gross margin | 33.9% | 81.3% |
| Net margin | 5.5% | −69.8% |
| P/E (TTM) | 15.8× | 4.3× |
| Price / sales | 1.0× | 3.5× |
| Net cash | -$650.8M | $319.0M |
| Dividend yield | 1.23% | — |
| Volatility (60d) | 30.4% | 21.7% |
| Short % of float | 4.9% | 10.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).